These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 7083785)
1. [Biopsy study of chronic alcoholic hepatopathies. Assessment of the steatosis in the course of arginine thiazolidinecarboxylate treatment]. Mauro G; Vigiani L Clin Ter; 1982 Feb; 100(4):359-74. PubMed ID: 7083785 [No Abstract] [Full Text] [Related]
2. [Clinico-pathological study of the therapeutic efficiency of carbamizole in the treatment of human alcoholic hepatitis]. Sánchez Lombraña JL; Pérez R; Rodrigo L; González M; Saavedra LG; Linares A; Arce D Rev Esp Enferm Apar Dig; 1984 Mar; 65(3):233-8. PubMed ID: 6729186 [No Abstract] [Full Text] [Related]
3. [Immunohistochemical studies on the occurrence of HBs antigen in alcoholic fatty liver and alcoholic fatty liver hepatitis]. Thaler H; Beham A Wien Klin Wochenschr; 1986 Mar; 98(5):151-5. PubMed ID: 3515768 [TBL] [Abstract][Full Text] [Related]
4. [Liver biopsy changes in chronic alcoholism]. Lorenz G Z Gesamte Inn Med; 1978 Mar; 33(5):145-8. PubMed ID: 645147 [TBL] [Abstract][Full Text] [Related]
5. [Chronic liver damage of alcoholics]. András K; Zsuzsa S; Károly L; Béla P; Imre V; János S Orv Hetil; 1978 Jun; 119(23):1409-12. PubMed ID: 662319 [No Abstract] [Full Text] [Related]
6. Characteristic features of liver disease in Japanese alcoholics. Sugimoto M; Hatori T; Ito T; Furube M; Abei T Am J Gastroenterol; 1985 Dec; 80(12):993-7. PubMed ID: 4073006 [TBL] [Abstract][Full Text] [Related]
7. [A clinico-pathological study of the liver damage in alcoholic patients]. Insunza I; Iturriaga H; Ugarte G; Altschiller H Rev Med Chil; 1969 Dec; 97(12):765-72. PubMed ID: 4157359 [No Abstract] [Full Text] [Related]
8. [5-year follow-up studies of alcoholic liver diseases]. Nagy G; Ujszászy L; Nagy K; Prónay G Orv Hetil; 1981 Jul; 122(27):1643-6. PubMed ID: 7290672 [No Abstract] [Full Text] [Related]
9. [Essential phospholipids in the treatment of alcohol-induced steatosis and hepatitis]. Katuscák I; Hendrich F; Vladár L; Valentík M; Horáková M; Lauko L Cas Lek Cesk; 1988 Apr; 127(18):556-9. PubMed ID: 3293785 [No Abstract] [Full Text] [Related]
13. [Toxic alcohol-induced, acute intrahepatic cholestasis with reversible increase of the CA 19-9 tumor marker in chronic alcoholic hepatitis]. Griga T; May B Z Gastroenterol; 1993 Feb; 31 Suppl 2():62-3. PubMed ID: 7483717 [TBL] [Abstract][Full Text] [Related]
14. Low-grade steatosis and major changes in portal flow as new prognostic factors in steroid-treated alcoholic hepatitis. Duvoux C; Radier C; Roudot-Thoraval F; Maille F; Anglade MC; Van Nhieu JT; Rosa I; Hospitel S; Abd-Alsamad I; Sitruk V; Seror O; Ziol M; Blondon H; Dhumeaux D; Richardet JP Hepatology; 2004 Dec; 40(6):1370-8. PubMed ID: 15565651 [TBL] [Abstract][Full Text] [Related]
15. [Effects of administration of arginine thiazolidinecarboxylate in liver pathology of various origins. Results of a multicenter study]. Gasbarrini G; Bernardi M Minerva Dietol Gastroenterol; 1982; 28(2):143-52. PubMed ID: 7099448 [No Abstract] [Full Text] [Related]
16. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Mathurin P; Beuzin F; Louvet A; Carrié-Ganne N; Balian A; Trinchet JC; Dalsoglio D; Prevot S; Naveau S Aliment Pharmacol Ther; 2007 May; 25(9):1047-54. PubMed ID: 17439505 [TBL] [Abstract][Full Text] [Related]
18. Alcoholic liver disease in man (1911-1979)--a probing review--Part II. Bhagwat AG; Islam M Indian J Pathol Microbiol; 1980 Jan; 23(1):73-87. PubMed ID: 7011958 [No Abstract] [Full Text] [Related]
19. Portal lymphocytic infiltrate in alcoholic liver disease. Colombat M; Charlotte F; Ratziu V; Poynard T Hum Pathol; 2002 Dec; 33(12):1170-4. PubMed ID: 12514784 [TBL] [Abstract][Full Text] [Related]
20. [Organ changes in chronic alcoholism]. Lao B Pol Tyg Lek; 1978 May; 33(18):743-5. PubMed ID: 351587 [No Abstract] [Full Text] [Related] [Next] [New Search]